Three principal barriers to cancer clinical trials:
“The best treatment for any cancer patient is on a clinical trial.”
DR. ROBERT S. MANNEL
Director, NCI Designated Stephenson Cancer Center
CanceRx goal is to bolster a robust clinical trial system that can move the new drug patents flowing out of the basic research phase into patient care. This would significantly improve cancer survivorship in the foreseeable future.
CanceRx acknowledges the importance of NCCN eligibility criteria and may not have the resources to change overall patient eligibility or influence insurance companies. However, CanceRx is designed to inject much-needed funding to overcome the most challenging healthcare provider and system coverage barriers.